-
公开(公告)号:US06686369B1
公开(公告)日:2004-02-03
申请号:US09155944
申请日:1998-10-08
申请人: Dagmar Klinge , Wilhelm Amberg , Ernst Baumann , Andreas Kling , Hartmut Riechers , Liliane Unger , Manfred Raschack , Stefan Hergenröder , Sabine Schult
发明人: Dagmar Klinge , Wilhelm Amberg , Ernst Baumann , Andreas Kling , Hartmut Riechers , Liliane Unger , Manfred Raschack , Stefan Hergenröder , Sabine Schult
IPC分类号: C07D23960
CPC分类号: C07D217/22 , C07D239/34 , C07D239/48 , C07D239/52 , C07D239/56 , C07D239/60 , C07D239/80 , C07D239/96 , C07D251/20 , C07D251/22 , C07D251/30 , C07D251/38 , C07D251/52 , C07D471/04 , C07D487/04 , C07D491/04
摘要: The present invention relates to carboxylic acid derivatives of the formula where the radicals have the meanings stated in the description, to the preparation of these compounds and to their use as drugs.
摘要翻译: 本发明涉及式的羧酸衍生物,其中自由基具有说明书中所述的含义,这些化合物的制备及其作为药物的用途。
-
公开(公告)号:US06103732A
公开(公告)日:2000-08-15
申请号:US155948
申请日:1998-10-08
申请人: Wilhelm Amberg , Andreas Kling , Dagmar Klinge , Hartmut Riechers , Ernst Baumann , Liliane Unger , Manfred Raschack , Stefan Hergenroder , Sabine Schult
发明人: Wilhelm Amberg , Andreas Kling , Dagmar Klinge , Hartmut Riechers , Ernst Baumann , Liliane Unger , Manfred Raschack , Stefan Hergenroder , Sabine Schult
IPC分类号: A61K31/00 , A61K31/47 , A61K31/505 , A61P9/00 , A61P9/12 , A61P13/00 , A61P13/12 , C07D215/22 , C07D215/227 , C07D239/34 , C07D239/60 , C07D401/12 , C07D403/12 , A61K31/44 , C07D213/68
CPC分类号: C07D215/227 , C07D239/34 , C07D239/60
摘要: Carboxylic acid derivatives of the formula I ##STR1## where the radicals have the meanings stated in the description, and the preparation of these agreements [sic] and their use as drugs are described.
摘要翻译: PCT No.PCT / EP97 / 01687 Sec。 371日期:1998年10月8日 102(e)日期1998年10月8日PCT 1997年4月4日PCT PCT。 公开号WO97 / 38982 日期1997年10月23日描述了式I的羧酸衍生物,其中基团具有说明书中所述的含义,以及这些协议的制备及其作为药物的用途。
-
3.Heterocyclic carboxylic acid derivatives, the production and use thereof as endothelin receptor antagonists 失效
标题翻译: 杂环羧酸衍生物,其作为内皮素受体拮抗剂的生产和用途公开(公告)号:US06448248B1
公开(公告)日:2002-09-10
申请号:US09319876
申请日:1999-06-14
申请人: Wilhelm Amberg , Rolf Jansen , Andreas Kling , Dagmar Klinge , Hartmut Riechers , Stefan Hergenröder , Manfred Raschack , Liliane Unger
发明人: Wilhelm Amberg , Rolf Jansen , Andreas Kling , Dagmar Klinge , Hartmut Riechers , Stefan Hergenröder , Manfred Raschack , Liliane Unger
IPC分类号: C07D253065
CPC分类号: C07D403/12 , C07D237/14 , C07D237/16 , C07D241/18 , C07D253/07 , C07D253/075 , C07D253/10 , C07D491/04
摘要: The present invention relates to carboxylic acid derivatives of the formula I where the substituents have the meanings explained in the description, and to preparation and use as endothelin receptor antagonists.
摘要翻译: 本发明涉及式I的羧酸衍生物,其中取代基具有说明书中解释的含义,以及作为内皮素受体拮抗剂的制备和用途。
-
公开(公告)号:US06004988A
公开(公告)日:1999-12-21
申请号:US29447
申请日:1998-02-24
申请人: Wilhelm Amberg , Andreas Kling , Dagmar Klinge , Hartmut Riechers , Liliane Unger , Manfred Raschack , Stefan Hergenroder , Bernd Elger , Sabine Schult
发明人: Wilhelm Amberg , Andreas Kling , Dagmar Klinge , Hartmut Riechers , Liliane Unger , Manfred Raschack , Stefan Hergenroder , Bernd Elger , Sabine Schult
IPC分类号: C07D317/02 , A61K31/00 , A61K31/19 , A61K31/192 , A61K31/34 , A61K31/341 , A61K31/343 , A61K31/35 , A61K31/352 , A61K31/357 , A61K31/36 , A61K31/435 , A61K31/44 , A61K31/505 , A61P9/00 , A61P9/08 , C07C53/134 , C07C57/30 , C07C57/32 , C07C57/38 , C07C59/64 , C07C69/616 , C07C69/734 , C07C255/00 , C07D213/55 , C07D213/64 , C07D221/04 , C07D239/26 , C07D239/34 , C07D239/52 , C07D239/70 , C07D257/04 , C07D307/79 , C07D317/50 , C07D317/60 , C07D319/02 , C07D319/18 , A61K31/275 , A61K31/41
CPC分类号: C07D213/64 , C07C57/30 , C07C57/38 , C07C59/64 , C07C69/616 , C07C69/734 , C07D213/55 , C07D221/04 , C07D239/26 , C07D239/34 , C07D239/52 , C07D239/70 , C07D307/79 , C07D317/60 , C07D319/18
摘要: Carboxylic acid derivatives of the formula I ##STR1## here R.sup.1 is a tetrazole [sic], nitrile [sic], a group COOH or a radical which can be hydrolyzed to COOH, and the other substituents have the meaning explained in the description.
摘要翻译: PCT No.PCT / EP96 / 03793 371日期:1998年2月24日 102(e)1998年2月24日PCT 1996年8月29日PCT PCT。 出版物WO97 / 09294 日期1997年3月13日本文R1中的羧酸衍生物R1是四唑基,腈基,COOH基团或可被水解成COOH的基团,其它取代基具有在说明书中解释的含义 。
-
5.Azinyloxy, and phenoxy-diaryl-carboxylic acid derivatives, their preparation and use as mixed ETA/ETB endothelin receptor antagonists 失效
标题翻译: 叠氮基氧基和苯氧基 - 二芳基羧酸衍生物,其制备和用作混合的ETA / ETB内皮素受体拮抗剂公开(公告)号:US06670367B1
公开(公告)日:2003-12-30
申请号:US09254137
申请日:1999-03-01
申请人: Wilhelm Amberg , Rolf Jansen , Andreas Kling , Dagmar Klinge , Hartmut Riechers , Stefan Hergenröder , Manfred Raschack , Liliane Unger
发明人: Wilhelm Amberg , Rolf Jansen , Andreas Kling , Dagmar Klinge , Hartmut Riechers , Stefan Hergenröder , Manfred Raschack , Liliane Unger
IPC分类号: C07D23934
CPC分类号: C07D239/70 , C07C59/66 , C07C69/734 , C07D239/34 , C07D239/52 , C07D239/60 , C07D491/04
摘要: The invention relates to carboxylic acid derivatives of the formula I where the radicals have the meanings stated in the description, and to their use as drugs.
摘要翻译: 本发明涉及式I的羧酸衍生物,其中基团具有说明书中所述的含义,以及它们作为药物的用途。
-
公开(公告)号:US07601730B2
公开(公告)日:2009-10-13
申请号:US11502293
申请日:2006-08-10
申请人: Hartmut Riechers , Dagmar Klinge , Wilhelm Amberg , Andreas Kling , Stefan Muller , Ernst Baumann , Joachim Rheinheimer , Uwe Josef Vogelbacher , Wolfgang Wernet , Liliane Unger , Manfred Raschack
发明人: Hartmut Riechers , Dagmar Klinge , Wilhelm Amberg , Andreas Kling , Stefan Muller , Ernst Baumann , Joachim Rheinheimer , Uwe Josef Vogelbacher , Wolfgang Wernet , Liliane Unger , Manfred Raschack
IPC分类号: A61P7/02
CPC分类号: C07D495/04 , C07D239/34 , C07D239/48 , C07D239/52 , C07D239/60 , C07D239/70 , C07D239/96 , C07D251/20 , C07D251/26 , C07D251/52 , C07D403/06 , C07D403/12 , C07D405/12 , C07D405/14 , C07D413/12 , C07D417/12 , C07D487/04 , C07D491/04 , C07D491/048
摘要: Carboxylic acid derivatives where R—R6, X, Y and Z have the meanings stated in the description, and the preparation thereof, are described. The novel compounds are suitable for controlling diseases.
-
公开(公告)号:US20070203338A1
公开(公告)日:2007-08-30
申请号:US11789630
申请日:2007-04-25
申请人: Hartmut Riechers , Dagmar Klinge , Wilhelm Amberg , Andreas Kling , Stefan Muller , Ernst Baumann , Joachim Rheinheimer , Uwe Vogelbacher , Wolfgang Wernet , Liliane Unger , Manfred Raschack
发明人: Hartmut Riechers , Dagmar Klinge , Wilhelm Amberg , Andreas Kling , Stefan Muller , Ernst Baumann , Joachim Rheinheimer , Uwe Vogelbacher , Wolfgang Wernet , Liliane Unger , Manfred Raschack
IPC分类号: C07D251/22 , C07D207/00 , C07D233/22 , C07D303/48 , C07D257/06 , C07D239/24
CPC分类号: C07D495/04 , C07D239/34 , C07D239/48 , C07D239/52 , C07D239/60 , C07D239/70 , C07D239/96 , C07D251/20 , C07D251/26 , C07D251/52 , C07D403/06 , C07D403/12 , C07D405/12 , C07D405/14 , C07D413/12 , C07D417/12 , C07D487/04 , C07D491/04 , C07D491/048
摘要: Carboxylic acid derivatives where R—R6, X, Y and Z have the meanings stated in the description, and the preparation thereof, are described. The novel compounds are suitable for controlling diseases.
摘要翻译: 其中R-R 6,X,Y和Z具有说明书中所述含义及其制备的羧酸衍生物。 新型化合物适用于控制疾病。
-
公开(公告)号:US20060276474A1
公开(公告)日:2006-12-07
申请号:US11502293
申请日:2006-08-10
申请人: Hartmut Riechers , Dagmar Klinge , Wilhelm Amberg , Andreas Kling , Stefan Muller , Ernst Baumann , Joachim Rheinheimer , Uwe Vogelbacher , Wolfgang Wernet , Liliane Unger , Manfred Raschack
发明人: Hartmut Riechers , Dagmar Klinge , Wilhelm Amberg , Andreas Kling , Stefan Muller , Ernst Baumann , Joachim Rheinheimer , Uwe Vogelbacher , Wolfgang Wernet , Liliane Unger , Manfred Raschack
IPC分类号: C07D251/48 , A61K31/53 , A61K31/513
CPC分类号: C07D495/04 , C07D239/34 , C07D239/48 , C07D239/52 , C07D239/60 , C07D239/70 , C07D239/96 , C07D251/20 , C07D251/26 , C07D251/52 , C07D403/06 , C07D403/12 , C07D405/12 , C07D405/14 , C07D413/12 , C07D417/12 , C07D487/04 , C07D491/04 , C07D491/048
摘要: Carboxylic acid derivatives where R-R6, X, Y and Z have the meanings stated in the description, and the preparation thereof, are described. The novel compounds are suitable for controlling diseases.
摘要翻译: 其中R-R 6,X,Y和Z具有说明书中所述含义及其制备的羧酸衍生物。 新型化合物适用于控制疾病。
-
公开(公告)号:US08349843B2
公开(公告)日:2013-01-08
申请号:US13267178
申请日:2011-10-06
申请人: Hartmut Riechers , Dagmar Klinge , Wilhelm Amberg , Andreas Kling , Stefan Muller , Ernst Baumann , Joachim Rheinheimer , Uwe Vogelbacher , Wolfgang Wernet , Andrea Hager-Wernet, legal representative , Liliane Unger , Manfred Raschack
发明人: Hartmut Riechers , Dagmar Klinge , Wilhelm Amberg , Andreas Kling , Stefan Muller , Ernst Baumann , Joachim Rheinheimer , Uwe Vogelbacher , Wolfgang Wernet , Liliane Unger , Manfred Raschack
IPC分类号: A61K31/505 , A61K31/517 , A61K31/519
CPC分类号: C07D495/04 , C07D239/34 , C07D239/48 , C07D239/52 , C07D239/60 , C07D239/70 , C07D239/96 , C07D251/20 , C07D251/26 , C07D251/52 , C07D403/06 , C07D403/12 , C07D405/12 , C07D405/14 , C07D413/12 , C07D417/12 , C07D487/04 , C07D491/04 , C07D491/048
摘要: Carboxylic acid derivatives where R—R6, X, Y and Z have the meanings stated in the description, and the preparation thereof, are described. The novel compounds are suitable for controlling diseases.
摘要翻译: 其中R-R6,X,Y和Z具有说明书中所述含义的羧酸衍生物及其制备。 新型化合物适用于控制疾病。
-
公开(公告)号:US07109205B2
公开(公告)日:2006-09-19
申请号:US10602275
申请日:2003-06-24
申请人: Hartmut Riechers , Dagmar Klinge , Wilhelm Amberg , Andreas Kling , Stefan Müller , Ernst Baumann , Joachim Rheinheimer , Uwe Josef Vogelbacher , Wolfgang Wernet , Liliane Unger , Manfred Raschack
发明人: Hartmut Riechers , Dagmar Klinge , Wilhelm Amberg , Andreas Kling , Stefan Müller , Ernst Baumann , Joachim Rheinheimer , Uwe Josef Vogelbacher , Wolfgang Wernet , Liliane Unger , Manfred Raschack
IPC分类号: C07D239/02 , A61K31/505
CPC分类号: C07D495/04 , C07D239/34 , C07D239/48 , C07D239/52 , C07D239/60 , C07D239/70 , C07D239/96 , C07D251/20 , C07D251/26 , C07D251/52 , C07D403/06 , C07D403/12 , C07D405/12 , C07D405/14 , C07D413/12 , C07D417/12 , C07D487/04 , C07D491/04 , C07D491/048
摘要: Carboxylic acid derivatives where R–R6, X, Y and Z have the meanings stated in the description, and the preparation thereof, are described. The novel compounds are suitable for controlling diseases.
摘要翻译: 其中R-R 6,X,Y和Z具有说明书中所述含义及其制备的羧酸衍生物。 新型化合物适用于控制疾病。
-
-
-
-
-
-
-
-
-